Fluticasone propionate
- Generic Name
- Fluticasone propionate
- Brand Names
- Advair, Airduo, Airduo Respiclick, Aller-flo, Armonair, Beser, Cutivate, Dymista, Flonase, Flovent, Fluticare, Ticanase, Wixela, Xhance
- Drug Type
- Small Molecule
- Chemical Formula
- C25H31F3O5S
- CAS Number
- 80474-14-2
- Unique Ingredient Identifier
- O2GMZ0LF5W
- Background
Fluticasone propionate is a synthetic glucocorticoid. These drugs are available as inhalers, nasal, sprays, and topical treatments for various inflammatory indications. Fluticasone propionate was first approved in 1990.
- Indication
Fluticasone propionate is indicated as an inhaler for the treatment and management of asthma by prophylaxisas well as inflammatory and pruritic dermatoses. Fluticasone propionate nasal spray is indicated for managing allergic and nonallergic rhinitis.
- Associated Conditions
- Allergic Rhinitis (AR), Allergy to Animal Dander, Allergy to Mold, Allergy to Tree Pollen, Asthma, Bacterial Sinusitis, Chronic Bronchitis, Chronic Obstructive Pulmonary Disease (COPD), Chronic Sinusitis, Dermatitis, Emphysema, Eosinophilic Esophagitis, House Dust Mite Allergy, House dust allergy, Itching of the nose, Nasal Congestion, Non-Allergic Rhinitis, Rhinitis, Rhinitis Perennial, Rhinorrhoea, Seasonal Allergic Rhinitis, Sneezing, Moderate, severe Perennial Allergic Rhinitis (PAR), Moderate, severe Seasonal Allergic Rhinitis
- Associated Therapies
- -
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
- Conditions
- Interventions
- First Posted Date
- 2008-04-17
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 607
- Registration Number
- NCT00660517
- Locations
- 🇺🇸
Southwest Allergy and Asthma Center, P.A., San Antonio, Texas, United States
🇺🇸Allergy and Asthma Care, Waco, Texas, United States
🇺🇸Sylvana Research Associates, San Antonio, Texas, United States
Inhaled Corticosteroids Versus Observation for Patients With Decreased Lung Function Status
- First Posted Date
- 2008-04-11
- Last Posted Date
- 2012-04-23
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 1
- Registration Number
- NCT00656916
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis
- Conditions
- Interventions
- First Posted Date
- 2008-04-09
- Last Posted Date
- 2008-04-09
- Lead Sponsor
- Greiner, Jack V., OD DO PhD
- Target Recruit Count
- 60
- Registration Number
- NCT00655109
- Locations
- 🇺🇸
Ophthalmic Research Associates, Inc, North Andover, Massachusetts, United States
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
- Conditions
- Interventions
- First Posted Date
- 2008-04-02
- Last Posted Date
- 2012-09-26
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 832
- Registration Number
- NCT00651118
- Locations
- 🇺🇸
Jane Lee, MD, PA Research Center, Dallas, Texas, United States
🇺🇸Allergy Research Foundation, Los Angeles, California, United States
🇺🇸Asthma, Inc., Seattle, Washington, United States
Rhinocort Aqua Versus Placebo and Fluticasone Propionate
- Conditions
- Interventions
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2011-01-24
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 750
- Registration Number
- NCT00641680
A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)
- Conditions
- First Posted Date
- 2008-02-12
- Last Posted Date
- 2016-11-03
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 55
- Registration Number
- NCT00612820
- Locations
- 🇦🇹
GSK Investigational Site, Vienna, Austria
Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in Asthma
- First Posted Date
- 2008-02-01
- Last Posted Date
- 2014-03-10
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 44
- Registration Number
- NCT00606242
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Leukotriene Receptor Antagonists or Steroids in Pre-School Asthma
- First Posted Date
- 2007-10-15
- Last Posted Date
- 2009-02-04
- Lead Sponsor
- Johann Wolfgang Goethe University Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT00543686
- Locations
- 🇩🇪
Goethe University, Department of Pulmonology, Frankfurt, Hessen, Germany
A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)
- Conditions
- Interventions
- First Posted Date
- 2007-10-08
- Last Posted Date
- 2022-02-14
- Lead Sponsor
- Organon and Co
- Registration Number
- NCT00540839
Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD
- Conditions
- Interventions
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2014-05-30
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 103
- Registration Number
- NCT00535366
- Locations
- 🇧🇪
1249.1.32002 Boehringer Ingelheim Investigational Site, Hasselt, Belgium
🇧🇪1249.1.32001 Boehringer Ingelheim Investigational Site, Gent, Belgium
🇳🇱1249.1.31003 Boehringer Ingelheim Investigational Site, Harderwijk, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.